Market closed

Ironwood Pharmaceuticals/$IRWD

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ticker

$IRWD
Trading on

Industry

Biotechnology

Employees

267

IRWD Metrics

BasicAdvanced
$563M
Market cap
-
P/E ratio
-$0.02
EPS
0.47
Beta
-
Dividend rate
$563M
0.47
$15.70
$3.51
1.3M
3.617
3.329
-196.477
-197.496
4.11%
18.45%
0.98%
1.471
-1.81
-1.79
4.495
-12.48%
-99.71%
-2.90%
-82.30%

What the Analysts think about IRWD

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Ironwood Pharmaceuticals stock.

IRWD Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

IRWD Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IRWD

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ironwood Pharmaceuticals stock?

Ironwood Pharmaceuticals (IRWD) has a market cap of $563M as of November 22, 2024.

What is the P/E ratio for Ironwood Pharmaceuticals stock?

The price to earnings (P/E) ratio for Ironwood Pharmaceuticals (IRWD) stock is 0 as of November 22, 2024.

Does Ironwood Pharmaceuticals stock pay dividends?

No, Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next Ironwood Pharmaceuticals dividend payment date?

Ironwood Pharmaceuticals (IRWD) stock does not pay dividends to its shareholders.

What is the beta indicator for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals (IRWD) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.